Kenvue (KVUE *) Stock Overview
Operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 2/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
KVUE * Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Kenvue Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$310.00 |
| 52 Week High | US$439.23 |
| 52 Week Low | US$285.01 |
| Beta | 0.67 |
| 1 Month Change | -12.68% |
| 3 Month Change | -20.51% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -17.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| KVUE * | MX Personal Products | MX Market | |
|---|---|---|---|
| 7D | 7.4% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how KVUE * performed against the MX Personal Products industry.
Return vs Market: Insufficient data to determine how KVUE * performed against the MX Market.
Price Volatility
| KVUE * volatility | |
|---|---|
| KVUE * Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine KVUE *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2022 | 22,000 | Kirk Perry | www.kenvue.com |
Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.
Kenvue Inc. Fundamentals Summary
| KVUE * fundamental statistics | |
|---|---|
| Market cap | Mex$592.56b |
| Earnings (TTM) | Mex$26.30b |
| Revenue (TTM) | Mex$280.79b |
Is KVUE * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KVUE * income statement (TTM) | |
|---|---|
| Revenue | US$15.14b |
| Cost of Revenue | US$6.34b |
| Gross Profit | US$8.81b |
| Other Expenses | US$7.39b |
| Earnings | US$1.42b |
Last Reported Earnings
Jun 29, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.74 |
| Gross Margin | 58.15% |
| Net Profit Margin | 9.37% |
| Debt/Equity Ratio | 80.2% |
How did KVUE * perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/13 12:02 |
| End of Day Share Price | 2025/10/10 00:00 |
| Earnings | 2025/06/29 |
| Annual Earnings | 2024/12/29 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Kenvue Inc. is covered by 23 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Lauren Lieberman | Barclays |
| Lauren Lieberman | Barclays |
| Navann Ty Dietschi | BNP Paribas Exane |